Aurélie Swalduz

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

Souad Assaad, Virginie Avrillon, Marie‐Line Fournier et al. · European Journal of Cancer · 2020 · 124 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux et al. · Journal of Thoracic Oncology · 2023 · 72 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting<i>ALK</i>and<i>ROS1</i>Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer

Laura Mezquita, Aurélie Swalduz, Cécile Jovelet et al. · JCO Precision Oncology · 2020 · 49 citations · Full text

Medicine, Genetics, Oncology +17

Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i> -Mutant Metastatic Non–Small Cell Lung Cancer

Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz et al. · Clinical Cancer Research · 2020 · 46 citations · Full text

Medicine, Molecular Genetics, Oncology +17

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz et al. · Cancer Discovery · 2024 · 45 citations · Full text

Medicine, Oncology, Pharmacology +13